Silo Pharma (SILO) investor group discloses 9.99% warrant-based ownership cap

Rhea-AI Filing Summary

Intracoastal Capital LLC and its principals report a significant ownership position in Silo Pharma, Inc. As of June 30, 2026, Mitchell P. Kopin, Daniel B. Asher and Intracoastal collectively report beneficial ownership of 125,261 shares of Silo common stock, representing 9.99% of the outstanding common stock. This stake is entirely issuable upon exercise of five warrants held by Intracoastal, with 125,261 shares from three warrants counted toward current beneficial ownership and additional shares from two warrants and part of a third excluded by blocker provisions that cap ownership at 9.99% or 4.99%. Without these blocker provisions, the reporting group indicates they could be deemed to beneficially own 222,995 shares. All voting and dispositive powers over the reported shares are shared, with no sole authority reported by any of the filers.

Key Figures

Beneficial ownership shares: 125,261 shares Percent of class: 9.99% Shares outstanding baseline: 1,128,610 shares +5 more

8 metrics

Beneficial ownership shares 125,261 shares Shares of Silo Pharma common stock beneficially owned as of June 30, 2026

Percent of class 9.99% Portion of Silo Pharma common stock represented by the reported beneficial ownership

Shares outstanding baseline 1,128,610 shares Common stock outstanding as of June 18, 2026, used in ownership calculation

Warrant 1 shares 55,556 shares Common shares issuable upon exercise of Intracoastal Warrant 1

Warrant 2 shares 55,556 shares Common shares issuable upon exercise of Intracoastal Warrant 2

Warrant 3 included shares 14,149 shares Common shares from Intracoastal Warrant 3 counted toward beneficial ownership

Potential shares without blockers 222,995 shares Total shares that may be deemed beneficially owned without blocker provisions

Excluded Warrant 3 shares 49,343 shares Additional Intracoastal Warrant 3 shares excluded due to 9.99% blocker

Key Terms

beneficial ownership, blocker provision, warrant, shared voting power, +2 more

6 terms

beneficial ownership financial

"each of the Reporting Persons may have been deemed to have beneficial ownership"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

blocker provision financial

"Intracoastal Warrant 3 contains a blocker provision under which the holder"

warrant financial

"shares of Common Stock issuable upon exercise of a warrant held by Intracoastal"

A warrant is a time-limited financial contract that gives its holder the right to buy a company's shares at a set price before a specified date, like a coupon that lets you purchase stock at a fixed discount for a limited time. It matters to investors because warrants offer leveraged exposure to a stock’s upside and can dilute existing shareholders if exercised, so they affect potential gains and the company’s outstanding share count.

shared voting power financial

"Shared Voting Power 125,261.00"

Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.

dispositive power financial

"Shared Dispositive Power 125,261.00"

Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.

Schedule 13G/A regulatory

"form_type: "SCHEDULE 13G/A""

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/13/2026 - 10:23 AM Accepted by SEC EDGAR 08/13/2026 - 10:21 AM Learn about SEC filing dates

FAQ

What percentage of Silo Pharma (SILO) does Intracoastal Capital report owning?

As of June 30, 2026, the reporting group states beneficial ownership of 9.99% of Silo Pharma’s common stock. This percentage is based on 1,128,610 shares outstanding plus certain warrant shares they are entitled to acquire.

How many Silo Pharma (SILO) shares are reported as beneficially owned?

The reporting persons disclose beneficial ownership of 125,261 shares of Silo Pharma common stock. These consist entirely of shares issuable upon exercise of three Intracoastal warrants included in the ownership calculation.

What warrants underpin Intracoastal’s Silo Pharma (SILO) stake?

The group’s 125,261-share stake comes from Intracoastal Warrants 1, 2 and 3 (55,556, 55,556 and 14,149 shares, respectively). Additional warrant shares are excluded due to ownership blocker provisions limiting percentage ownership.

What are the blocker provisions affecting Silo Pharma (SILO) warrant exercises?

Certain Intracoastal warrants include blocker provisions that prevent exercises raising ownership above 9.99% or 4.99%. Because of these limits, 97,734 warrant shares are excluded from current beneficial ownership calculations.

How many Silo Pharma (SILO) shares could be owned without blocker limits?

Without the blocker provisions, the reporting persons indicate they may be deemed to beneficially own 222,995 shares of Silo Pharma common stock. This figure includes all shares issuable from five Intracoastal warrants.

Who are the reporting persons in this Silo Pharma (SILO) Schedule 13G/A?

The filing is made on behalf of Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC. Kopin and Asher are U.S. individuals, and Intracoastal is a Delaware limited liability company.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 4)

Silo Pharma, Inc.

(Name of Issuer)

Common stock, par value $0.0001 per share

(Title of Class of Securities)

82711P300

(CUSIP Number)

06/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 82711P300

1

Names of Reporting Persons

Mitchell P. Kopin

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 125,261.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 125,261.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

125,261.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.99 %

12

Type of Reporting Person (See Instructions)

HC, IN

SCHEDULE 13G

CUSIP Number(s): 82711P300

1

Names of Reporting Persons

Daniel B. Asher

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 125,261.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 125,261.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

125,261.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.99 %

12

Type of Reporting Person (See Instructions)

HC, IN

SCHEDULE 13G

CUSIP Number(s): 82711P300

1

Names of Reporting Persons

Intracoastal Capital LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 125,261.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 125,261.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

125,261.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.99 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Silo Pharma, Inc.
(b)	Address of issuer's principal executive offices: 677 N. Washington Boulevard, Sarasota, FL 34236
Item 2.
(a)	Name of person filing: This Schedule 13G is being filed on behalf of (i) Mitchell P. Kopin, an individual ("Mr. Kopin"), (ii) Daniel B. Asher, an individual ("Mr. Asher") and (iii) Intracoastal Capital LLC, a Delaware limited liability company ("Intracoastal" and together with Mr. Kopin and Mr. Asher, collectively the "Reporting Persons").
(b)	Address or principal business office or, if none, residence: The principal business office of Mr. Kopin and Intracoastal is 245 Palm Trail, Delray Beach, Florida 33483. The principal business office of Mr. Asher is 1011 Lake Street, Suite 311, Oak Park, Illinois 60301.
(c)	Citizenship: Mr. Kopin is a citizen of the United States of America. Mr. Asher is a citizen of the United States of America. Intracoastal is a Delaware limited liability company.
(d)	Title of class of securities: Common stock, par value $0.0001 per share
(e)	CUSIP No.: 82711P300
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: As of the close of business on June 30, 2026, each of the Reporting Persons may have been deemed to have beneficial ownership of 125,261 shares of Common Stock, which consisted of (i) 55,556 shares of Common Stock issuable upon exercise of a warrant held by Intracoastal ("Intracoastal Warrant 1") and (ii) 55,556 shares of Common Stock issuable upon exercise of a second warrant held by Intracoastal ("Intracoastal Warrant 2") and (iii) 14,149 shares of Common Stock issuable upon exercise of a third warrant held by Intracoastal ("Intracoastal Warrant 3"), and all such shares of Common Stock represent beneficial ownership of approximately 9.99% of the Common Stock, based on (1) 1,128,610 shares of Common Stock outstanding as of June 18, 2026, as reported by the Issuer, plus (2) 55,556 shares of Common Stock issuable upon exercise of Intracoastal Warrant 1, (3) 55,556 shares of Common Stock issuable upon exercise of Intracoastal Warrant 2 and (4) 14,149 shares of Common Stock issuable upon exercise of Intracoastal Warrant 3. The foregoing excludes (I) 49,343 shares of Common Stock issuable upon exercise of Intracoastal Warrant 3 because Intracoastal Warrant 3 contains a blocker provision under which the holder thereof does not have the right to exercise Intracoastal Warrant 3 to the extent (but only to the extent) that such exercise would result in beneficial ownership by the holder thereof, together with the holder's affiliates, and any other persons acting as a group together with the holder or any of the holder's affiliates, of more than 9.99% of the Common Stock, (II) 22,936 shares of Common Stock issuable upon exercise of a fourth warrant held by Intracoastal ("Intracoastal Warrant 4") because Intracoastal Warrant 4 contains a blocker provision under which the holder thereof does not have the right to exercise Intracoastal Warrant 4 to the extent (but only to the extent) that such exercise would result in beneficial ownership by the holder thereof, together with the holder's affiliates, and any other persons acting as a group together with the holder or any of the holder's affiliates, of more than 4.99% of the Common Stock and (III) 25,455 shares of Common Stock issuable upon exercise of a fifth warrant held by Intracoastal ("Intracoastal Warrant 5") because Intracoastal Warrant 5 contains a blocker provision under which the holder thereof does not have the right to exercise Intracoastal Warrant 5 to the extent (but only to the extent) that such exercise would result in beneficial ownership by the holder thereof, together with the holder's affiliates, and any other persons acting as a group together with the holder or any of the holder's affiliates, of more than 4.99% of the Common Stock. Without such blocker provisions, each of the Reporting Persons may have been deemed to have beneficial ownership of 222,995 shares of Common Stock.
(b)	Percent of class: 9.99%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 125,261
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: 125,261
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Mitchell P. Kopin

Signature:	/s/ Mitchell P. Kopin
Name/Title:	Mitchell P. Kopin
Date:	08/13/2026

Daniel B. Asher

Signature:	/s/ Daniel B. Asher
Name/Title:	Daniel B. Asher
Date:	08/13/2026

Intracoastal Capital LLC

Signature:	/s/ Mitchell P. Kopin
Name/Title:	Mitchell P. Kopin, Manager
Date:	08/13/2026